Sundyota Numandis enters into a strategic alliance with Finzelberg (Germany) to exclusively represent the German phyto-pharmaceuticals major in India

ERr731– a patented plant derived therapy from Finzelberg to be unveiled shortly for the Indian market to ease symptoms during menopause.

Ahmedabad, February 15, 2018: Sundyota Numandis Group of Companies has sealed a strategic alliance with Finzelberg, Germany to offer novel, natural healthcare productsin India. To start with, Sundyota Numandis will introduce ERr731, a product complimenting women’s health during menopause and peri-menopause for the first time in India.

Sundyota Numandis is a global health-oriented organization focused on providing safe healthcare products and clinically proven therapies from non-synthetic sources. Finzelberg is a business unit of the Martin Bauer Group(Germany) and is a distinguished name in the manufacturing of superior grade phyto-pharmaceuticals and phyto-nutraceuticals. The Martin Bauer Group is a supplier of herbal and fruit infusions, medicinal teas, flavored black and green teas, aromas, herbal powders, botanicals, herbal, fruit and tea extracts.

As part of the pact, Sundyota Numandis will procure active ingredients from Finzelberg, undertake their formulation and development and seek registration and regulatory approvalsof the same. This will be shortly followed by commercial manufacturing along with product launch, marketing and co-marketing through promotion to doctors and other leading pharmaceutical companies in India.

The new product unveiled today aims to ease over 20 symptoms related to menopause and peri-menopause such as hot flushes, sweating, joint & muscle pain, vaginal dryness,sleep disturbances, anxiety,low mood, irritability and works on specific beta-estrogenreceptors, thus acting as a natural female hormone. Being completely devoid of any side effects over long term use, it has an unmatched safety profile.

“SundyotaNumandis is a specialist in providing supportive and preventivetherapies. We now have 12 international alliances to foster healthcare the natural way along with over 60 patented and exclusive therapies. Our partnership with Finzelberg will center around knowledge-sharing to drive research and innovation.

ERr731 marks the beginning of an enriching journey and is safer than any currently available therapy for menopause. It facilitates a smooth transition for women experiencing menopause.We are really happy to have Finzelberg on board to share this novel product,” said Dinesh Kumar Arora, MD CEO, SundyotaNumandis Group of Companies. 

In due course, the partnership will widen its scope of concurrence and look at developing a series of new molecules addressing need gaps in Indian healthcare, best suited to the Indian population and patient profile. 

Dr.Rene Roth-Ehrang, Member of the Management Board, Sales & Marketing said, “On behalf of the Finzelberg Management board, I would like to express the pleasure and honor we feel that Sundyota Numandis has chosen our company as a partner for introducing new phyto pharmaceuticals in India. When I first met Sundyota, I was very impressed by their competencies. They are one of the most innovative pharmaceutical companies. I was impressed by the values of Sundyota and their vision. Finzelberg is a family-owned German extract manufacturer with a tradition since 1875. It’s a family owned company and we’re also driven by strong values of family and social responsibility. Finzelberg and Sundyota not only share strong values but also the passion for natural health.”

Some innovation-driven products on the anvil are natural anti-microbial cure for upper respiratory tract infections, a cough syrup that promises zero side-effects and, a dedicated product for heavy and fatigued legs caused due to Chronic Venous Insufficiency. 

Dr.Rainer Kunz, Area Sales Manager, Europe, Middle East & India said, “We have finalized the discussions with our friends from Sundyota on our first project end of last month. We are very, very happy. More projects will follow providing modern phyto-pharmaceutical solutionsfor today’s lifestyle. We are looking forward to a very fruitful and happy partnership”.

SundyotaNumandis has been listed among the top 50 of India’s Most Promising Brands 2016, compiled by the World Consulting & Research Corporation and has a motivated team of over 500 people. Finzelberg produces more than 800 different products for customers all over the globe using state-of-the-art methods to gently extract the natural healing powers of leaves, flowers, barks, roots, seeds and fruits.

This strategic alliance between SundyotaNumandis and Finzelberg will facilitate the availability of some of the finest and safest healthcare products for the Indian population.

Corporate Comm India(CCI Newswire)